3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Myelodysplastic Syndromes
33
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
20
Myeloproliferative Disorders
18
Leukemia, Biphenotypic, Acute
18
Hematologic Neoplasms
18
Leukemia, Lymphocytic, Chronic, B-Cell
16
Lymphoma, Non-Hodgkin
15
Hodgkin Disease
15
Multiple Myeloma
14
Leukemia, Myelomonocytic, Chronic
13
Leukemia
12
Anemia, Refractory, with Excess of Blasts
11
Primary Myelofibrosis
10
Lymphoma, Follicular
10
Lymphoma, Mantle-Cell
9
Burkitt Lymphoma
9
Lymphoma, B-Cell, Marginal Zone
8
Lymphoma
8
Lymphoma, T-Cell
7
Leukemia, Prolymphocytic
7
Anemia, Aplastic
7
Leukemia, Myeloid
6
Graft vs Host Disease
6
Waldenstrom Macroglobulinemia
5
Polycythemia Vera
5
Lymphoma, Large B-Cell, Diffuse
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Accelerated Phase
4
Interventions
Dexamethasone
3
Bortezomib
3
Cyclophosphamide
2
Clinical Protocols
2
isatuximab
1
daratumumab
1
Tissue Banks
1
Rifaximin
1
Lenalidomide
1
Clonal Hematopoiesis
1
Chromatin Immunoprecipitation Sequencing
1
CLR1404
1
Blood Cell Count
1
ARQ531
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Paraproteinemias
×
Whole-Body Irradiation
×
1 year
×
Clear all
No trials found.